Elsevier

JACC: Heart Failure

Volume 8, Issue 8, August 2020, Pages 657-666
JACC: Heart Failure

Focus Issue: RV Dysfunction and HFpEF
Clinical Research
Hemodynamic and Functional Impact of Epicardial Adipose Tissue in Heart Failure With Preserved Ejection Fraction

https://doi.org/10.1016/j.jchf.2020.04.016Get rights and content
Under an Elsevier user license
open archive

Abstract

Objectives

This study determined the impact of excess epicardial adipose tissue (EAT) in patients with the obese phenotype of heart failure with preserved ejection fraction (HFpEF).

Background

Patients with HFpEF and an elevated body mass index differ from nonobese patients, but beyond generalized obesity, fat distribution may be more important. Increases in EAT are associated with excess visceral adiposity, inflammation, and cardiac fibrosis, and EAT has been speculated to play an important role in the pathophysiology of HFpEF, but no study has directly evaluated this question.

Methods

Patients with HFpEF and obesity (n = 169) underwent invasive hemodynamic exercise testing with expired gas analysis and echocardiography. Increased EAT was defined by echocardiography (EAT thickness ≥9 mm).

Results

Compared with obese patients without increased EAT (HFpEFEAT−, n = 92), obese patients with HFpEF with increased EAT (HFpEFEAT+; n = 77) displayed a higher left ventricular eccentricity index, indicating increased pericardial restraint, but similar resting biventricular structure and function. In contrast, hemodynamics were more abnormal in patients with HFpEFEAT+, with higher right atrial, pulmonary artery, and pulmonary capillary wedge pressures at rest and during exercise compared with those of patients with HFpEFEAT−. Peak oxygen consumption (VO2) was reduced in both groups but was 20% lower in patients with HFpEFEAT+ (p < 0.01).

Conclusions

Among patients with the obese phenotype of HFpEF, the presence of increased EAT is associated with more profound hemodynamic derangements at rest and exercise, including greater elevation in cardiac filling pressures, more severe pulmonary hypertension, and greater pericardial restraint, culminating in poorer exercise capacity. Further study is needed to understand the biology and treatment of excessive EAT in patients with HFpEF.

Key Words

epicardial fat
heart failure
hemodynamics
HFpEF
obesity
pericardium
pulmonary hypertension

Abbreviations and Acronyms

A- VO2diff
arterial-venous oxygen content difference
BMI
body mass index
CI
cardiac index
EAT
epicardial adipose tissue
HFpEF
heart failure with preserved ejection fraction
HFpEFEAT+
HFpEF with increased EAT
HFpEFEAT−
without increased EAT
LV
left ventricular
LVecc
left ventricular eccentricity index
PA
pulmonary artery
PCWP
pulmonary capillary wedge pressure
RA
right atrial
Rideal/Ractual
idealized to actual LV radius
RV
right ventricular
VO2
oxygen consumption

Cited by (0)

Dr. Borlaug is supported by the National Institutes of Health (NIH) (R01 HL128526, R01 HL 126638, U01 HL125205, and U10 HL110262). Ms. Koepp is supported by the NIH (F31 HL143952). The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC: Heart Failure author instructions page.